| Homology modeling in drug discovery: Overview, current applications, and future perspectives MT Muhammed, E Aki‐Yalcin Chemical biology & drug design 93 (1), 12-20, 2019 | 416 | 2019 |
| Synthesis and structure–activity relationships of new antimicrobial active multisubstituted benzazole derivatives I Yildiz-Oren, I Yalcin, E Aki-Sener, N Ucarturk European Journal of Medicinal Chemistry 39 (3), 291-298, 2004 | 381 | 2004 |
| Synthesis and antimicrobial activity of some novel 2, 5-and/or 6-substituted benzoxazole and benzimidazole derivatives İ Ören, Ö Temiz, I Yalçın, E Şener, N Altanlar European journal of pharmaceutical sciences 7 (2), 153-160, 1999 | 180 | 1999 |
| The synthesis and the structure-activity relationships of some substituted benzoxazoles, oxazolo (4, 5-b) pyridines, benzothiazoles and benzimidazoles as antimicrobial agents İ Yalçin, İ Ören, E Şener, A Akin, N Uçartürk European journal of medicinal chemistry 27 (4), 401-406, 1992 | 159 | 1992 |
| Some benzoxazoles and benzimidazoles as DNA topoisomerase I and II inhibitors E Oksuzoglu, B Tekiner-Gulbas, S Alper, O Temiz-Arpaci, T Ertan, I Yildiz, ... Journal of enzyme inhibition and medicinal chemistry 23 (1), 37-42, 2008 | 157 | 2008 |
| Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents T Ertan, I Yildiz, B Tekiner-Gulbas, K Bolelli, O Temiz-Arpaci, S Ozkan, ... European journal of medicinal chemistry 44 (2), 501-510, 2009 | 144 | 2009 |
| Some fused heterocyclic compounds as eukaryotic topoisomerase II inhibitors A Pinar, P Yurdakul, I Yildiz, O Temiz-Arpaci, NL Acan, E Aki-Sener, ... Biochemical and Biophysical Research Communications 317 (2), 670-674, 2004 | 143 | 2004 |
| Synthesis and HIV-1 reverse transcriptase inhibitor activity of some 2, 5, 6-substituted benzoxazole, benzimidazole, benzothiazole and oxazolo (4, 5-b) pyridine derivatives A Akbay, İI Ören, Ö Temiz-Arpacı, E Akı-Sener, I Yalcçın Arzneimittelforschung 53 (04), 266-271, 2003 | 140 | 2003 |
| Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl) carboxamido] benzoxazoles S Alper-Hayta, M Arisoy, Ö Temiz-Arpaci, I Yildiz, E Aki, S Özkan, ... European journal of medicinal chemistry 43 (11), 2568-2578, 2008 | 126 | 2008 |
| Synthesis and microbiological activity of some novel 5-or 6-methyl-2-(2, 4-disubstituted phenyl) benzoxazole derivatives Ö Temiz, İ Ören, E Şener, I Yalcin, N Uçartürk Il Farmaco 53 (5), 337-341, 1998 | 124 | 1998 |
| Synthesis and microbiological activity of 5-methyl-2-[p-substituted phenyl] benzoxazoles İ Yalçın, E Şener, T Özden, S Özden, A Akın European Journal of Medicinal Chemistry 25 (8), 705-708, 1990 | 108 | 1990 |
| Some new bi-and ter-benzimidazole derivatives as topoisomerase I inhibitors S Alper, ÖT Arpaci, EŞ Aki, I Yalçin Il Farmaco 58 (7), 497-507, 2003 | 106 | 2003 |
| A target site for template-based design of measles virus entry inhibitors RK Plemper, KJ Erlandson, AS Lakdawala, A Sun, A Prussia, ... Proceedings of the National Academy of Sciences 101 (15), 5628-5633, 2004 | 104 | 2004 |
| Vibrational spectroscopic (FT-IR, FT-Raman, 1H NMR and UV) investigations and computational study of 5-nitro-2-(4-nitrobenzyl) benzoxazole JB Bhagyasree, HT Varghese, CY Panicker, J Samuel, C Van Alsenoy, ... Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 102, 99-113, 2013 | 100 | 2013 |
| In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis M Martins, Z Schelz, A Martins, J Molnar, G Hajös, Z Riedl, M Viveiros, ... International journal of antimicrobial agents 29 (3), 338-340, 2007 | 99 | 2007 |
| Synthesis, antimicrobial activity and QSARs of new benzoxazine-3-ones S Alper-Hayta, E Akı-Sener, B Tekiner-Gulbas, I Yıldız, O Temiz-Arpacı, ... European journal of medicinal chemistry 41 (12), 1398-1404, 2006 | 98 | 2006 |
| Molecular Docking: Principles, Advances, and its Applications in Drug Discovery EAY Muhammed Tilahun Muhammed Letters in Drug Design & Discovery 29 (7), 1-29, 2022 | 88* | 2022 |
| High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II‐targeting drugs H Lage, E Aki‐Sener, I Yalcin International journal of cancer 119 (1), 213-220, 2006 | 79 | 2006 |
| Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials A Ridho, S D Alfian, JFM Boven, J Levita, E Aki-Yalcin, ... Journal of Medical Internet Research 24 (2), 1-13, 2022 | 71 | 2022 |
| Synthesis and biological activity of some new benzoxazoles Ö Temiz-Arpacı, İ Yıldız, S Oezkan, F Kaynak, E Akı-Şener, İ Yalçın European journal of medicinal chemistry 43 (7), 1423-1431, 2008 | 70 | 2008 |
ozlem temiz arpaciankara üniversitesi確認したメール アドレス: pharmacy.ankara.edu.tr